Belgium temporarily restricts the use of the Oxford–AstraZeneca vaccine to people over 55 years old following a report from the European Medicines Agency that there is a "possible link" between the vaccine and very rare blood clotting cases.
Estonia suspends the use of the Oxford–AstraZeneca vaccine to people over 60 years old following report of possible link with the blood clotting cases.
TheMinistryofHealthtemporarilyrestricts the use of the Oxford–AstraZeneca vaccine to people over 60 years old following areport of a"possible link" with veryrareblood clotting.
Estonia suspends the use of the Oxford–AstraZeneca vaccine in people under 60 years old following a report of a possible link with casesof blood clotting.
TheMinistryofHealthrestricts the use of the Oxford–AstraZeneca vaccine to people over 60 years old following a report of a "possible link" with veryrare blood clotting.
Estonia suspends the use of the Oxford–AstraZeneca vaccine by people under 60 years old following a report of a possible link with casesof blood clotting.
Belgiumtemporarilyrestricts the use of the Oxford–AstraZeneca vaccine to people over 55 years old following a report fromtheEuropeanMedicinesAgencythatthereisa"possible link"betweenthevaccineandveryrare blood clottingcases.
